Skyline Biotech Private Limited
About Skyline Biotech Private Limited
Data last updated:
Skyline Biotech Private Limited is a private limited company based in Sangli, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 12 February 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Pune, under CIN U24239PN2021PTC198594. Its GSTIN is 27ABFCS4658B1ZB (Maharashtra).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Pramod Jaykumar Wategave and Bhalchandra Virendra Patil.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at S No 373/2/2 2B Dhamani Road Awati Motors, Sangli, Maharashtra, India – 416416.
As per the financials filed for FY 2025, the company reported a revenue of ₹71,875. For the same year it recorded a net loss of ₹1.82 Lakh (net margin -253.1%) and EBITDA of -₹1.82 Lakh (EBITDA margin -253.1%). Revenue has declined at a compounded annual rate (CAGR) of 63% over three years.
Company details
Contact details
Skyline Biotech Private Limited's registered office is in Sangli, Maharashtra.
- Registered AddressS No 373/2/2 2B Dhamani Road Awati Motors, Sangli, Maharashtra, India – 416416
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Skyline Biotech Private Limited
FY 2025 filings availableSkyline Biotech Private Limited reported revenue of ₹71,875 for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 63% over three years. EBITDA fell 16% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹1.82 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹1.82 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -253.1% | ||||
| Net Profit Margin | -253.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Skyline Biotech Private Limited, buy the company report.
Board of directors of Skyline Biotech Private Limited
Skyline Biotech has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Pramod Jaykumar Wategave Also directs: Skylark Precitech Private Limited | Director | 12 Feb 2021 | 5 Years 9 Months | Current |
| Bhalchandra Virendra Patil Also directs: Swastik Infra Landmark (India) LLP, Skylark TMS LLP, Biosphere Consultancy LLP and 3 more | Director | 12 Feb 2021 | 5 Years 9 Months | Current |
Peer comparison
Skyline Biotech Private Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (Formulations), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Atcg Lifesciences Private Limited | ₹78,008 (FY 2024) | -20.0% | Ahmedabad, Gujarat, India | |||
| Open Source Pharma Foundation | ₹76,099 (FY 2025) | -58.0% | Bangalore, Karnataka, India | |||
| Albay Pharmaceuticals Private Limited | ₹74,806 (FY 2023) | 19032.0% | Delhi, India | |||
| Cronus Research Labs Private Limited | ₹74,430 (FY 2025) | -94.0% | Hyderabad, Telangana, India | |||
| Ayuurleiutis Solutions Private Limited | ₹73,066 (FY 2025) | -66.0% | Nagaur, Rajasthan, India | |||
| Skyline Biotech Private Limitedthis company | ₹71,875 (FY 2025) | -₹1.82 Lakh | -253.1% | Sangli, Maharashtra, India | ||
| Allianz Biotech Private Limited | ₹71,198 (FY 2024) | 82.0% | Chennai, Tamil Nadu, India | |||
| Balusu Pharma Private Limited | ₹71,054 (FY 2023) | 166.0% | Hyderabad, Telangana, India | |||
| Kismat Medi Care Private Limited | ₹71,000 (FY 2025) | 1075.0% | Bharuch, Gujarat, India | |||
| Aulea Healthcare Private Limited | ₹70,835 (FY 2024) | -75.0% | Southwestdelhi, Delhi, India | |||
| Sunway Life Sciences Private Limited | ₹70,620 (FY 2025) | 21.0% | Hyderabad, Telangana, India |
To see the full peer comparison of Skyline Biotech Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Skyline Biotech Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Skyline Biotech Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Skyline Biotech has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27ABFCS4658B1ZB | Maharashtra | Active | 23 Feb 2021 |
To see the full GST registrations and return filing status of Skyline Biotech Private Limited, buy the company report.
Recent activity
Skyline Biotech Private Limited has 2 board changes on record since 2021: 2 appointments. The latest: Bhalchandra Virendra Patil was appointed as Director on 12 Feb 2021.
Frequently asked questions
Skyline Biotech is an active private limited company based in Sangli, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 12 February 2021 (5+ years old) and is registered under CIN U24239PN2021PTC198594.
Skyline Biotech has 2 current directors:
- Pramod Jaykumar Wategave - Director
- Bhalchandra Virendra Patil - Director
The latest financial statements of Skyline Biotech on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Skyline Biotech is 27ABFCS4658B1ZB, registered in Maharashtra.
The CIN (Corporate Identification Number) of Skyline Biotech is U24239PN2021PTC198594. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Skyline Biotech was incorporated on 12 February 2021, making it 5+ years old. It is registered with the Registrar of Companies, Pune.
The peers of Skyline Biotech by revenue are Atcg Lifesciences Private Limited, Open Source Pharma Foundation, Albay Pharmaceuticals Private Limited, Cronus Research Labs Private Limited, Ayuurleiutis Solutions Private Limited and 5 more, all in the Pharma industry (Formulations).
Bhalchandra Virendra Patil was appointed as Director on 12 Feb 2021. Pramod Jaykumar Wategave was appointed as Director on 12 Feb 2021.
The registered office of Skyline Biotech is at S No 37322 2B Dhamani Road Awati Motors, Sangli, Maharashtra, India – 416416.
Skyline Biotech operates in the pharma industry, in the drug formulation and development segment.
Skyline Biotech can be reached at its registered office: S No 37322 2B Dhamani Road Awati Motors, Sangli, Maharashtra, India – 416416.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
